LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 74.97 | 17.25 | 1303 | 5618 | 0.2319 | 0.6788 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 74.97 | 17.25 | 6126 | 5618 | 1.0903 | 1.0208 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.94 | 17.25 | 42 | 5681 | 0.0074 | 0.1123 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.94 | 17.25 | 5994 | 5681 | 1.0550 | 1.0128 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.94 | 17.25 | 1139 | 5681 | 0.2005 | 0.6504 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.94 | 17.25 | 6269 | 5681 | 1.1034 | 1.0237 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.91 | 17.25 | 42 | 5730 | 0.0073 | 0.1121 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.91 | 17.25 | 6139 | 5730 | 1.0713 | 1.0165 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.91 | 17.25 | 1072 | 5730 | 0.1871 | 0.6372 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.91 | 17.25 | 6432 | 5730 | 1.1224 | 1.0278 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.88 | 17.25 | 48 | 5826 | 0.0082 | 0.1296 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.88 | 17.25 | 6282 | 5826 | 1.0783 | 1.0180 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.88 | 17.25 | 593 | 5826 | 0.1018 | 0.5237 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.88 | 17.25 | 6573 | 5826 | 1.1282 | 1.0289 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.85 | 17.25 | 46 | 5861 | 0.0078 | 0.1237 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.85 | 17.25 | 6384 | 5861 | 1.0891 | 1.0204 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.85 | 17.25 | 367 | 5861 | 0.0626 | 0.4385 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.85 | 17.25 | 6729 | 5861 | 1.1480 | 1.0331 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.82 | 17.25 | 38 | 5924 | 0.0064 | 0.0983 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.82 | 17.25 | 6556 | 5924 | 1.1067 | 1.0242 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.82 | 17.25 | 163 | 5924 | 0.0275 | 0.3055 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.82 | 17.25 | 6834 | 5924 | 1.1536 | 1.0342 | MN20160310_N02 | N04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.79 | 17.25 | 11 | 6008 | 0.0018 | -0.0519 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.79 | 17.25 | 6657 | 6008 | 1.1080 | 1.0244 | MN20160310_N02 | K22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.79 | 17.25 | 103 | 6008 | 0.0171 | 0.2357 | MN20160310_N02 | N04 |